The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usa...

FDA Device Recall #Z-1299-2021 — Class II — February 8, 2021

Recall Summary

Recall Number Z-1299-2021
Classification Class II — Moderate risk
Date Initiated February 8, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Meridian Bioscience Inc
Location Cincinnati, OH
Product Type Devices
Quantity 8 kits

Product Description

The ImmunoCard Mycoplasma EIA detects the presence of IgM to M. pneumoniae in serum - Product Usage: intended to aid in the diagnosis of recent Mycoplasma pneumoniae infection.

Reason for Recall

Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.

Distribution Pattern

US Nationwide distribution in the states of OH, SC.

Lot / Code Information

Catalog Number: 709030, Lot Number: 709030M114, Device Identifier: 00840733101762.

Other Recalls from Meridian Bioscience Inc

Recall # Classification Product Date
Z-1019-2026 Class II Revogene C. difficile, in vitro diagnostic assa... Dec 5, 2025
Z-0568-2026 Class II Meridian Bioscience, alethia c. Difficile, Cat... Oct 7, 2025
Z-0569-2026 Class II Meridian Bioscience, Group B Streptococcus, Cat... Oct 7, 2025
Z-0520-2024 Class II Para-Pak Zn-PVA/10% Formalin-for the routine co... Oct 19, 2023
Z-0521-2024 Class II Cardinal Health Clean Stool Transportation Syst... Oct 19, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.